Skip to search formSkip to main contentSkip to account menu

Pyridinolcarbamate

Known as: Pyricarbate, Pyridinolcarbamate [Chemical/Ingredient], 2,6-Pyridinedimethanol-bis-(N-methylcarbamate) 
A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders… 
National Institutes of Health

Related topics

Related topics

14 relations

Narrower (5)

AngininAngioxineP-23Parmidine

Broader (1)

Hypolipidemic Agents
In BloodNitroglycerinagonistsanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1977
1977
A Multiclinic Double-Blind Trial of Pyridinolcarbamate and Inositol Niacinate in Ischemic Ulcer Due To Chronic Arterial Occlusion
A double-blind multiclinic trial compared the efficacies of pyridinolcarba mate and inositol niacinate in the patients with the… 
1975
1975
Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders.
The hyperreactive arterial endothelial cells have been introduced in this paper. They are characterized by their ability to… 
Highly Cited
1973
Highly Cited
1973
Effect of histamine, bradykinin and morphine on adrenaline release from rat adrenal gland.
Abstract Effects of histamine, bradykinin and morphine on adrenaline secretion from rat adrenal gland were investigated by means… 
1973
1973
Systemic Effects of ADP-induced Platelet Aggregation and Their Modification by Aspirin and by Pyridinolcarbamate
Summary ADP, AMP, or ATP was injected rapidly intravenously in rats. ADP injection resulted in the f olio wing transient changes… 
1973
1973
Enhancement of ADP-Induced Platelet Aggregation by Cholesterol and Its Prevention by Pyridinolcarbamate
Summary The authors reported a transient decrease in adhesive platelet count and an enhancement of blood coagulability after… 
1973
1973
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
Treatment with pyridinolcarbamate for obstructive diseases of the peripheral arteries could be evaluated in 21 patients. The… 
Review
1972
Review
1972
New concept on atherogenesis and treatment of atherosclerotic diseases.
"Das initiale fettfreie Odem" has been long known by the German school as the initial stage of human atherosclerosis, and a… 
1971
1971
Appearance of Thrombogenic Tendency Induced by Adrenaline and Its Prevention by β-Adrenergic Blocking Agent, Nialamide and Pyridinolcarbamate
Summary In 52 men and 33 women, the total, adhesive and nonadhesive platelet counts, onestage prothrombin time, euglobulinlysis… 
1971
1971
Effect of pyridinolcarbamate on platelet aggregation
AbstractADP-induced platelet aggregation, assessed by employing a microscopic method, was enhanced by Intravenous Injection of 1… 
1969
1969
EXPERIMENTAL STUDY ON ATHEROSCLEROSIS –AN ATTEMPT AT ITS PREVENTION AND TREATMENT
Electron microscopical analysis of endothelial linings of the aortic lumen and of the vasa vasorum was made in man, rhesus monkey… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)